Blue Rock Advisors’s Clorox CLX Stock Holding History

Blue Rock Advisors’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-3,000	Closed	-$400K	–	65
2017 Q2	$400K	Buy	+3,000	New	+$405K	0.6%	42

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VAM

ValueInvest Asset Management Luxembourg $1.47B AUM 0.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Blue Rock Advisors's CLX Position: Q3 2017 in Review

Blue Rock Advisors sold out of Clorox (CLX) in Q3 2017, closing a stake of 3,000 shares — an estimated $400K sold.

Blue Rock Advisors first reported a position in CLX in Q2 2017 and held it in 1 quarter. The position peaked at $400K in Q2 2017. 857 funds tracked by Wall St. Rank hold CLX as of Q3 2017.

Blue Rock Advisors reported no remaining Clorox position as of Q3 2017 after selling out during the quarter.
Blue Rock Advisors sold 3,000 Clorox shares in Q3 2017, an estimated $400K.
Blue Rock Advisors first reported a position in Clorox in Q2 2017 and held it in 1 quarter.
Blue Rock Advisors's Clorox position peaked at $400K in Q2 2017.
857 funds tracked by Wall St. Rank held Clorox as of Q3 2017.

Based on Blue Rock Advisors's 13F filing for Q3 2017, filed 8 Nov 2017.